文拉法辛联合双歧三联活菌及马来酸曲美布汀对难治性肠易激综合征的疗效分析

被引:17
作者
高玲 [1 ]
李明泉 [2 ]
机构
[1] 陕西省甘泉县人民医院消化内科
[2] 陕西省延安市人民医院消化内科
关键词
文拉法辛; 双歧三联活菌; 马来酸曲美布汀; 难治性肠易激综合征;
D O I
暂无
中图分类号
R574.4 [肠道功能紊乱];
学科分类号
100201 [内科学];
摘要
目的研究抗抑郁药文拉法新联合双歧三联活菌及马来酸曲美布汀对难治性肠易激综合征的临床疗效。方法选择在甘泉县人民医院进行诊治的难治性肠易激综合征患者120例,随机分为观察组与对照组,每组各60例。对照组给予双歧三联活菌及马来酸曲美布汀进行常规的胃肠药物治疗,观察组在此基础上联合应用文拉法辛,疗程均为3个月。采用消化道症状频率指数和症状程度指数对患者的临床消化道症状进行评分、用汉密尔顿焦虑量表(HAMA)及汉密尔顿抑郁量表(HAMD)对患者精神状态进行评分。结果观察组的有效率为93.33%,明显高于对照组的68.33%(P<0.05);治疗后两组的消化道症状频率指数和症状程度指数均明显降低(P<0.05),且观察组明显低于对照组(P<0.05);治疗后两组的HAMD和HAMA评分均明显降低(P<0.05),且观察组明显低于对照组(P<0.05);观察组的不良反应主要为头痛、恶心、便秘,均发生在用药1周内,并于第2周消失。结论难治性肠易激综合征患者普遍存在焦虑和抑郁等情绪障碍,采用抗抑郁药文拉法新联合双歧三联活菌及马来酸曲美布汀可以使患者躯体和精神两方面的症均得到明显改善,值得应用推广。
引用
收藏
页码:592 / 594
页数:3
相关论文
共 11 条
[1]
口服双歧、嗜酸乳杆菌,肠球菌三联活菌胶囊辅助治疗溃疡性结肠炎 [J].
邢军 ;
李国华 ;
陈江 ;
曾晟 ;
吕农华 ;
廖旺娣 ;
李宝莲 ;
徐萍 ;
王健 .
中国新药与临床杂志, 2007, (07) :527-530
[2]
肠易激综合征的药物治疗 [J].
刘新光 .
现代消化及介入诊疗, 2007, (02) :102-105
[3]
临床肝胆病学.[M].叶维法;钟振义主编;.天津科学技术出版社.1998,
[4]
Depression and Somatization Are Associated With Increased Postprandial Symptoms in Patients With Irritable Bowel Syndrome [J].
Van Oudenhove, Lukas ;
Tornblom, Hans ;
Storsrud, Stine ;
Tack, Jan ;
Simren, Magnus .
GASTROENTEROLOGY, 2016, 150 (04) :866-874
[5]
Cognitive Functions and Depression in Patients with Irritable Bowel Syndrome.[J].Per G. Farup;Knut Hestad;Leticia Moreira.Gastroenterology Research and Practice.2015,
[6]
Altered faecal and mucosal microbial composition in post-infectious irritable bowel syndrome patients correlates with mucosal lymphocyte phenotypes and psychological distress [J].
Sundin, J. ;
Rangel, I. ;
Fuentes, S. ;
Heikamp-de Jong, I. ;
Hultgren-Hornquist, E. ;
de Vos, W. M. ;
Brummer, R. J. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 41 (04) :342-351
[7]
Bacterial Reaction Centers Purified with Styrene Maleic Acid Copolymer Retain Native Membrane Functional Properties and Display Enhanced Stability<link href="#nss"/>.[J].David J. K. Swainsbury;Stefan Scheidelaar;Rienk van Grondelle;J. Antoinette Killian;Michael R. Jones.Angew. Chem. Int. Ed..2014, 44
[8]
Serum-Derived Bovine Immunoglobulin/Protein Isolate Therapy for Patients with Refractory Irritable Bowel Syndrome.[J].Leonard B. Weinstock;Victoria S. Jasion.Open Journal of Gastroenterology.2014, 10
[9]
Review article: linaclotide for the management of irritable bowel syndrome with constipation [J].
Layer, P. ;
Stanghellini, V. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (04) :371-384
[10]
A biomarker panel and psychological morbidity differentiates the irritable bowel syndrome from health and provides novel pathophysiological leads [J].
Jones, M. P. ;
Chey, W. D. ;
Singh, S. ;
Gong, H. ;
Shringarpure, R. ;
Hoe, N. ;
Chuang, E. ;
Talley, N. J. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (04) :426-437